276 related articles for article (PubMed ID: 9632812)
21. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
[TBL] [Abstract][Full Text] [Related]
22. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
[TBL] [Abstract][Full Text] [Related]
23. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
Broudy VC; Lin NL
Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
[TBL] [Abstract][Full Text] [Related]
24. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
Ooi J; Tojo A; Asano S; Sato Y; Oka Y
Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.
Hong Y; Dumènil D; van der Loo B; Goncalves F; Vainchenker W; Erusalimsky JD
Blood; 1998 Feb; 91(3):813-22. PubMed ID: 9446641
[TBL] [Abstract][Full Text] [Related]
27. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
28. Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
J Cell Sci; 2002 Jun; 115(Pt 11):2329-37. PubMed ID: 12006617
[TBL] [Abstract][Full Text] [Related]
29. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
[TBL] [Abstract][Full Text] [Related]
30. A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cells.
Dorsch M; Danial NN; Rothman PB; Goff SP
Blood; 1999 Oct; 94(8):2676-85. PubMed ID: 10515871
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.
Matsumura I; Kitamura T; Wakao H; Tanaka H; Hashimoto K; Albanese C; Downward J; Pestell RG; Kanakura Y
EMBO J; 1999 Mar; 18(5):1367-77. PubMed ID: 10064602
[TBL] [Abstract][Full Text] [Related]
32. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction by the receptors for thrombopoietin (c-mpL) and interleukin-3 in hematopoietic and nonhematopoietic cells.
Morella KK; Bruno E; Kumaki S; Lai CF; Fu J; Wang HM; Murray L; Hoffman R; Timour M; Bénit L
Blood; 1995 Jul; 86(2):557-71. PubMed ID: 7605989
[TBL] [Abstract][Full Text] [Related]
35. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
36. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.
Liu RY; Fan C; Garcia R; Jove R; Zuckerman KS
Blood; 1999 Apr; 93(7):2369-79. PubMed ID: 10090948
[TBL] [Abstract][Full Text] [Related]
38. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation.
Gurney AL; Wong SC; Henzel WJ; de Sauvage FJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5292-6. PubMed ID: 7777500
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
40. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
